Found: 10
Select item for more details and to access through your institution.
Quantifying the Need for Specialist Palliative Care Management in Patients With Systemic Sclerosis.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 7, p. 964, doi. 10.1002/acr.25325
- By:
- Publication type:
- Article
Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease.
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1874, doi. 10.1093/rheumatology/kead491
- By:
- Publication type:
- Article
Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 6, p. 760, doi. 10.1002/acr.25311
- By:
- Publication type:
- Article
The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 269, doi. 10.1007/s10067-023-06796-1
- By:
- Publication type:
- Article
Rituximab treatment for systemic sclerosis‐associated interstitial lung disease: a case series of 13 patients.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 7, p. 1147, doi. 10.1111/imj.15832
- By:
- Publication type:
- Article
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03059-x
- By:
- Publication type:
- Article
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-15062-4
- By:
- Publication type:
- Article
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis.
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 849, doi. 10.1093/rheumatology/keaa332
- By:
- Publication type:
- Article